CANBRIDGE PHARMACEUTICALS INC. 北海康成製藥有限公司
Pay for financial year ended 2024-12-31
Source: Annual report
Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
| 1 | Chan, Peng Kuan 陳炳鈞 | INED | 323 | 323 | ||||
| 2 | Chen, Kan (1981) 陳侃 | NED | ||||||
| 3 | Geraghty, James Arthur | INED | 323 | 323 | ||||
| 4 | Gregory, Richard James (1958) | INED | 323 | 323 | ||||
| 5 | Hu, Edward 胡正國 | NED | ||||||
| 6 | Hu, Lan (SFC:AIB984) 胡瀾 | INED | 323 | 323 | ||||
| 7 | Li, Fangxin | NED | ||||||
| 8 | Xue, James Qun 薛群 | Ch, CEO, Fdr | 5,233 | 200 | 1,675 | 7,108 | ||
| Total | 1,292 | 5,233 | 0 | 200 | 1,675 | 8,400 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | 1,292 | 5,233 | 0 | 200 | 1,675 | 8,400 | Report |
| 2023-12-31 | 1,271 | 5,710 | 0 | 139 | 3,696 | 10,816 | Report |
| 2022-12-31 | 814 | 4,968 | 0 | 125 | 8,025 | 13,932 | Report |
| 2021-12-31 | 485 | 4,421 | 0 | 128 | 5,749 | 10,783 | Report |
| Total | 3,862 | 20,332 | 0 | 592 | 19,145 | 43,931 |
Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!
Copyright & disclaimer, Privacy policy